ONdrugDelivery - ONdrugDelivery - drug delivery industry specialised b2b information

YPSOMATE ON – GO FOR SIMPLY CONNECTED

Ypsomed's Philippe Müller and Silas Mächler discuss the benefits of integrated digital therapy management systems and the role of YpsoMate On – the world’s first prefilled autoinjector with integrated connectivity that automatically logs injections on the user’s therapy management app.

TOWARDS A NEW STANDARD OF CARE WITH APTAR PHARMA’S DIGITAL HEALTH

Adam Shain discusses how Aptar is building on the progress made in connected drug delivery devices to help realise their full potential by developing an open, end-to-end platform that will enable healthcare stakeholders to take a holistic view of the full drug delivery journey.

TRIALS WITHOUT TRIBULATIONS: A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED AND HYBRID CLINICAL TRIALS

Rebecca Beck and Hervé Monchoix discuss how stakeholder needs are driving the development of a new, connected injection device from BD, to support decentralised and hybrid clinical trials.

HOW MINIATURISED LIQUID FLOW SENSORS ARE REVOLUTIONISING SUBCUTANEOUS DRUG DELIVERY

HOW MINIATURISED LIQUID FLOW SENSORS ARE REVOLUTIONISING SUBCUTANEOUS DRUG DELIVERY

Andreas Alt and Susanne Pianezzi describe the drivers accelerating industry trends towards both wearable subcutaneous injection devices and connecting such devices to monitor patient dosing, providing a number of benefits.

“SOFTWARE AS A MEDICAL DEVICE” FROM A HUMAN FACTORS PERSPECTIVE

“SOFTWARE AS A MEDICAL DEVICE” FROM A HUMAN FACTORS PERSPECTIVE

Natalie Shortt discusses the considerations and steps to take when planning usability engineering efforts for software as a medical device.

MATERIAL SELECTION FOR NEXT-GENERATION CONNECTED MEDICAL ELECTRONICS

Miriam Kingsley

MATERIAL SELECTION FOR NEXT-GENERATION CONNECTED MEDICAL ELECTRONICS

Miriam Kingsley, Marcus Jarman-Smith and Thomas Billings highlight the growing array of applications for high-performance polymers in electronic and connected medical devices and how proper material selection is crucial, providing a guide to successful material selection, going on to showcase its APTIV™ PEEK polymer film, which is well suited to meet the specific demands of next-generation connected medical devices.

eFLOW TECHNOLOGY NEBULISERS WITH DIGITAL THERAPY MANAGEMENT: THE PARI CONNECT ECO-SYSTEM

Dr Carola Fuchs

eFLOW TECHNOLOGY NEBULISERS WITH DIGITAL THERAPY MANAGEMENT: THE PARI CONNECT ECO-SYSTEM

Carola Fuchs and Simon Buchner describe PARI’s new nebuliser and digital Connect eco-system and how it supports patients, directly and indirectly, through carefully considered device usability in combination with digital therapy management solutions.

Interview: Arnaud Guillet, Biocorp

Interview: Arnaud Guillet, Biocorp

In this exclusive interview with ONdrugDelivery, Arnaud Guillet discusses Mallya, Biocorp’s connected clip-on for pen injectors, including Mallya’s successful launch in multiple countries this year, the factors that have played into the device’s success, and the future for Mallya, Biocorp and connectivity in the drug delivery industry.

USING BLOCKCHAIN AND DATA ANALYTICS FOR IMPROVED MEDICAL CANNABIS EFFICACY

Global Cannabis Applications Corp

USING BLOCKCHAIN AND DATA ANALYTICS FOR IMPROVED MEDICAL CANNABIS EFFICACY

Brad Moore and Tim Morch describe GCAC’s technology offering, a blockchain-based software system that is able to transparently track the progress of medical cannabis from cultivation through to consumption.

Excipient Choices and Why They Matter in Topical Formulations

Bora Pharmaceutical CDMO

Excipient Choices and Why They Matter in Topical Formulations

Daryl Bassett and David Barnes show how the choice of common excipients can have a material impact on manufacturing success, quality and, ultimately, commercial success for topical formulations, which generally require the incorporation of more excipients than other products to deliver their API payload effectively.

MIGRATING A DRUG PRODUCT PRESENTATION FROM VIAL TO PREFILLED SYRINGE

PREFILLED SYRINGES

Dr Martin Gonzalez

Pfizer CentreOne

MIGRATING A DRUG PRODUCT PRESENTATION FROM VIAL TO PREFILLED SYRINGE

Martin Gonzalez discusses some of the most relevant engineering activities that are necessary to transfer a product successfully from a vial into a prefilled syringe presentation.

CHARACTERISING WALL THICKNESS OF QUALI-V<sup>®</sup>-I CAPSULES & ITS EFFECT ON CAPSULE PUNCTURE BY A DPI PIN

CHARACTERISING WALL THICKNESS OF QUALI-V^®-I CAPSULES & ITS EFFECT ON CAPSULE PUNCTURE BY A DPI PIN

Siamac Parker, Sion Coulman, Prof James Birchall alongside Susana Ecenarro and Mahmoud Farag, present a study that uses optical coherence tomography to characterise the wall thickness of capsules at the dome position and investigates the importance of controlling the dome thickness of hard-shell capsules to be used in a dry powder inhaler.

ADDRESSING THE CHALLENGES OF NASAL BIOTHERAPEUTIC DRUG DELIVERY

ADDRESSING THE CHALLENGES OF NASAL BIOTHERAPEUTIC DRUG DELIVERY

Robert Lee discusses the benefits of administering drugs to the nasal cavity, as well as the main challenges in formulation for this route and the strategies that can be applied to overcome them.

MAKING THE CONNECTION BETWEEN EFFICACY AND ENVIRONMENTAL SUSTAINABILITY

Andreas Meliniotis

MAKING THE CONNECTION BETWEEN EFFICACY AND ENVIRONMENTAL SUSTAINABILITY

Andreas Meliniotis looks at the factors that should be considered when designing devices with a view to sustainable connectivity.

POWDER CHARACTERISATION: A CRITICAL TOOL FOR THE EVOLUTION OF INHALED DRUG DELIVERY

POWDER CHARACTERISATION: A CRITICAL TOOL FOR THE EVOLUTION OF INHALED DRUG DELIVERY

Jamie Clayton, Joana Pinto and Sarah Zellnitz discuss the benefits of multi-faceted powder characterisation in dry powder inhalation formulations and how it can support efforts to achieve net zero emissions.

LEVERAGING HUMAN FACTORS TO DEVELOP PATIENT-CENTRIC INHALERS

Raphaële Audibert

LEVERAGING HUMAN FACTORS TO DEVELOP PATIENT-CENTRIC INHALERS

Raphaële Audibert, Mark Tunkel and Manuela Basso look at the role patient-centricity has to play in the development of inhalers to treat chronic respiratory diseases.

NUMERICAL SIMULATIONS FOR INHALATION PRODUCT DEVELOPMENT: ACHIEVEMENTS AND CURRENT LIMITATIONS

Dr Andrea Benassi

NUMERICAL SIMULATIONS FOR INHALATION PRODUCT DEVELOPMENT: ACHIEVEMENTS AND CURRENT LIMITATIONS

Andrea Benassi and Ciro Cottini discuss the current state of CFD and DEM computational modelling, how it is used to improve inhaler design and manufacturing, and what the current limitations of this technology are, as well as how those limitations may be overcome.

IMPROVING IN VITRO TEST METHODS FOR NASAL DRUG PRODUCTS

Copley Scientific

IMPROVING IN VITRO TEST METHODS FOR NASAL DRUG PRODUCTS

Mark Copley and Anna Sipitanou look at how in vitro testing is being refined for greater repeatability to maximise its value as a low-cost tool for product development, including an assessment of the role of automation in improving the sensitivity of in vitro testing.

TOWARDS A MORE SUSTAINABLE FUTURE WITH pMDI SOLUTIONS

TOWARDS A MORE SUSTAINABLE FUTURE WITH pMDI SOLUTIONS

Howard Burnett, Chris Baron and Jay Bhogaita summarise the findings of a recent forum that looked at the development of more sustainable pressurised metered dose inhalers.

DELIVERING ON THE PROMISES OF INTRANASAL VACCINATION

DELIVERING ON THE PROMISES OF INTRANASAL VACCINATION

Julie Suman and Nektaria Karavas review intranasal delivery as a method of vaccine administration and consider the challenges and benefits of intranasal delivery.

ROUNDTABLE: CAPSULE-BASED DRY POWDER INHALERS

Frédérique Bordes-Picard

ROUNDTABLE: CAPSULE-BASED DRY POWDER INHALERS

Frédérique Bordes-Picard of Lonza, Marco Franza of Berry, Mirjam Kobler of Meggle, and Marco Laackmann of Harro Höfliger, discuss the accelerating development potential of capsule-based dry powder inhalers (DPIs) and the potential of these effective and efficient drug delivery devices in the modern drug delivery market.

TRANSFORMING DRUG DELIVERY WITH SYNERGISTIC WORKING

TRANSFORMING DRUG DELIVERY WITH SYNERGISTIC WORKING

Bas van Driel discusses how expert collaborations can help develop a knowledge base to transform drug delivery and manufacturing. He shares how recent collaborative research projects involving lactose-based dry powder inhalation formulations, with and without magnesium stearate and lactose as an excipient in 3D tablet printing, have done just that.

Respiratory Drug Delivery (RDD<sup>®</sup> 2022)

1st May 2022 - 5th May 2022

Orlando, FL, USA

Respiratory Drug Delivery (RDD^® 2022)

RDD^® 2022 will be in-person at the Omni Orlando Champions Gate, Orlando, FL, US, and will include: Knowledge Spaces; Prominent researchers & key opinion leaders; Explore with Experts discussion sessions; Posters; Workshops; Exhibit tables; Networking events; The Charles G. Thiel and RDD VCU Peter R. Byron Graduate Student awards; and Peer-reviewed electronic proceedings.

ROUNDTABLE: ALLIANCE TO ZERO

Sebastian Gerner

Alliance to Zero

ROUNDTABLE: ALLIANCE TO ZERO

Sebastian Gerner, Robert O’Beirn and Sabrina Gérard talk with ONdrugDelivery about the Alliance to Zero, an association for pharma and biotech supply chain companies that aims to facilitate the transition of the pharma sector to compliance with net-zero emissions.

SIX INHALER SUSTAINABILITY MYTHS – AND WHY THEY MUST BE BUSTED

Kindeva Drug Delivery

SIX INHALER SUSTAINABILITY MYTHS – AND WHY THEY MUST BE BUSTED

Louise Righton busts six sustainability myths about inhalers.

STRATEGIES TO ACHIEVE LONG-TERM SUSTAINABILITY

STRATEGIES TO ACHIEVE LONG-TERM SUSTAINABILITY

Peter Soelkner and Thomas Otto discuss how the pharmaceutical service provider focuses on sustainability.

PLASMA TECHNOLOGY – THE FUTURE OF RESPIRATORY DEVICES

Jacqueline Green

PLASMA TECHNOLOGY – THE FUTURE OF RESPIRATORY DEVICES

Jacqueline Green discusses how H&T Presspart’s plasma treatment process can provide a future-proof and sustainable solution for some of the issues associated with suspension formulations in the respiratory device industry.

SUSTAINABILITY, WASTE & REMANUFACTURING IN THE MEDICAL SECTOR

SUSTAINABILITY, WASTE & REMANUFACTURING IN THE MEDICAL SECTOR

Cormac O’Prey discusses some of the sustainability challenges facing the medical sector, such as how to make re-use and remanufacturing viable for high-volume, low-value products, and how answers can be found by looking to successful solutions deployed by other industries.

SUSTAINABILITY WITH THE ARIA AUTOINJECTOR: A LIFECYCLE ASSESSMENT

Phillips-Medisize

SUSTAINABILITY WITH THE ARIA AUTOINJECTOR: A LIFECYCLE ASSESSMENT

Emil Fraenkel and Bjarne Sørensen consider the sustainability of re-usable and disposable autoinjectors, its implications in adding connectivity to drug delivery devices and how it has been an important consideration for Phillips-Medisize in the development of the Aria re-usable autoinjector.

PHARMAPACK EUROPE DRUG DELIVERY AND PACKAGING ANNUAL SURVEY 2021

PHARMAPACK EUROPE DRUG DELIVERY AND PACKAGING ANNUAL SURVEY 2021

Pharmapack presents the results of its annual survey and market report, covering the latest Pharmapack Innovation Index and the inaugural Pharmapack Sustainability Index, and taking stock of where the survey results suggest the pharma industry currently is, and where it is heading, in terms of innovation and sustainability.

FORMULATION DEVELOPMENT AND DRUG DELIVERY: JOINED AT THE DEVICE

Julie Cotterell

FORMULATION DEVELOPMENT AND DRUG DELIVERY: JOINED AT THE DEVICE

Julie Cotterell discusses the major factors at play driving the direction of innovation in the subcutaneous drug delivery space, with a particular emphasis on the push towards patient self-administration.

IMPORTANT CONSIDERATIONS WHEN DESIGNING FOR SUSTAINABILITY

Mr Michael Kiely

Jabil Healthcare

IMPORTANT CONSIDERATIONS WHEN DESIGNING FOR SUSTAINABILITY

Michael Kiely, Gerard Linnane and Justin Carroll discuss how implementing a thoughtful design-for-sustainability process can ensure medical devices not only improve patients’ lives but are also kinder to the environment.

EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY

EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY

Charlie Dean, Kay Sinclair and Brennan Miles provide an overview of eight terms key to a common understanding in the ongoing, and crucial, discussion surrounding sustainability.

CREATING TIMELESS DEVICE TECHNOLOGIES

CREATING TIMELESS DEVICE TECHNOLOGIES

Andrew Moore and Gene Rhode Fuensalida Pantig discuss the importance of a sound strategy for product lifecycle management.

INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT

Mathias Romacker

INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT

In this exclusive interview, Mathias Romacker discusses a broad range of topics, from his professional expertise and history seeing the parenteral sector evolve first-hand, to his personal experience as a Crohn’s disease patient making use of the very devices he’s seen grow and develop.

RELENTLESS PRECISION DELIVERS VALUE IN NEEDLE-HANDLING AUTOMATION FOR COMBINATION PRODUCTS

INDUSTRIALISATION

William Jaworski

Mikron Automation

RELENTLESS PRECISION DELIVERS VALUE IN NEEDLE-HANDLING AUTOMATION FOR COMBINATION PRODUCTS

William Jaworski and Michael Gunner discuss the precision and complex manipulation of needles required for the latest combination medical products.

FULLY AUTOMATED ASSEMBLY AND FUNCTIONAL TESTING FOR PEN INJECTORS AND AUTOINJECTORS

Carsten Köhler

FULLY AUTOMATED ASSEMBLY AND FUNCTIONAL TESTING FOR PEN INJECTORS AND AUTOINJECTORS

Carsten Köhler, Umit Ismail Tsavous and Gerd Vosshage explain the company’s processes for the automated assembly and testing of pen and autoinjectors.

CHALLENGES IN HIGH-VISCOSITY, HIGH-VOLUME DRUG DELIVERY

CHALLENGES IN HIGH-VISCOSITY, HIGH-VOLUME DRUG DELIVERY

Michael Roe discusses the development of the Aerio™ Platform of gas-powered injection systems.

THREE PHASES TO SUCCESS IN STERILE INJECTABLES TECHNOLOGY TRANSFER

Pfizer CentreOne

THREE PHASES TO SUCCESS IN STERILE INJECTABLES TECHNOLOGY TRANSFER

Jennifer Quint offers insights into how to plan and execute technology transfer effectively, explaining Pfizer CentreOne’s three-phased approach that can successfully support this pivotal event in a drug product programme’s journey to commercialisation.

1
2
3
…
28
Next

See what ondrugdelivery's readers and contributors think

Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.

Donna Bibber
President
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.

Abby Lockwood
Consultant
Plan Strategic

ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.

Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.

Top